| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8630358 | Diabetes Research and Clinical Practice | 2017 | 28 Pages |
Abstract
Our results demonstrate that fasting C-peptide and GADab status, but not age at onset, define groups of patients with diabetes with clinically relevant differences in glycaemic control and cardiometabolic risk.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Mette Wod, Knud B. Yderstræde, Ulrich Halekoh, Henning Beck-Nielsen, Kurt Højlund,